161 related articles for article (PubMed ID: 37106355)
21. Spectrum of CLCN1 mutations in patients with myotonia congenita in Northern Scandinavia.
Sun C; Tranebjaerg L; Torbergsen T; Holmgren G; Van Ghelue M
Eur J Hum Genet; 2001 Dec; 9(12):903-9. PubMed ID: 11840191
[TBL] [Abstract][Full Text] [Related]
22. Identification of five new mutations and three novel polymorphisms in the muscle chloride channel gene (CLCN1) in 20 Italian patients with dominant and recessive myotonia congenita. Mutations in brief no. 118. Online.
Sangiuolo F; Botta A; Mesoraca A; Servidei S; Merlini L; Fratta G; Novelli G; Dallapiccola B
Hum Mutat; 1998; 11(4):331. PubMed ID: 10215406
[TBL] [Abstract][Full Text] [Related]
23. Thomsen or Becker myotonia? A novel autosomal recessive nonsense mutation in the CLCN1 gene associated with a mild phenotype.
Gurgel-Giannetti J; Senkevics AS; Zilbersztajn-Gotlieb D; Yamamoto LU; Muniz VP; Pavanello RC; Oliveira AB; Zatz M; Vainzof M
Muscle Nerve; 2012 Feb; 45(2):279-83. PubMed ID: 22246887
[TBL] [Abstract][Full Text] [Related]
24. Congenital myotonia: a review of twenty cases and a new splice-site mutation in the CLCN1 gene.
Özgün N; Taşlıdere H
Turk J Pediatr; 2020; 62(3):450-460. PubMed ID: 32558419
[TBL] [Abstract][Full Text] [Related]
25. Functional and Structural Characterization of ClC-1 and Na
Brenes O; Barbieri R; Vásquez M; Vindas-Smith R; Roig J; Romero A; Valle GD; Bermúdez-Guzmán L; Bertelli S; Pusch M; Morales F
Cells; 2021 Feb; 10(2):. PubMed ID: 33670307
[TBL] [Abstract][Full Text] [Related]
26. The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene.
Reilich P; Horvath R; Krause S; Schramm N; Turnbull DM; Trenell M; Hollingsworth KG; Gorman GS; Hans VH; Reimann J; MacMillan A; Turner L; Schollen A; Witte G; Czermin B; Holinski-Feder E; Walter MC; Schoser B; Lochmüller H
J Neurol; 2011 Nov; 258(11):1987-97. PubMed ID: 21544567
[TBL] [Abstract][Full Text] [Related]
27. Heterozygous CLCN1 mutations can modulate phenotype in sodium channel myotonia.
Furby A; Vicart S; Camdessanché JP; Fournier E; Chabrier S; Lagrue E; Paricio C; Blondy P; Touraine R; Sternberg D; Fontaine B
Neuromuscul Disord; 2014 Nov; 24(11):953-9. PubMed ID: 25088311
[TBL] [Abstract][Full Text] [Related]
28. PNPLA2 mutation: a paediatric case with early onset but indolent course.
Perrin L; Féasson L; Furby A; Laforêt P; Petit FM; Gautheron V; Chabrier S
Neuromuscul Disord; 2013 Dec; 23(12):986-91. PubMed ID: 24074500
[TBL] [Abstract][Full Text] [Related]
29. Translating genetic and functional data into clinical practice: a series of 223 families with myotonia.
Suetterlin K; Matthews E; Sud R; McCall S; Fialho D; Burge J; Jayaseelan D; Haworth A; Sweeney MG; Kullmann DM; Schorge S; Hanna MG; Männikkö R
Brain; 2022 Apr; 145(2):607-620. PubMed ID: 34529042
[TBL] [Abstract][Full Text] [Related]
30. Becker's myotonia: novel mutations and clinical variability in patients born to consanguineous parents.
Sahin I; Erdem HB; Tan H; Tatar A
Acta Neurol Belg; 2018 Dec; 118(4):567-572. PubMed ID: 29480456
[TBL] [Abstract][Full Text] [Related]
31. Novel mutations in the muscle chloride channel CLCN1 gene causing myotonia congenita in Spanish families.
de Diego C; Gámez J; Plassart-Schiess E; Lasa A; Del Río E; Cervera C; Baiget M; Gallano P; Fontaine B
J Neurol; 1999 Sep; 246(9):825-9. PubMed ID: 10525982
[TBL] [Abstract][Full Text] [Related]
32. Novel PNPLA2 gene mutations in Chinese Han patients causing neutral lipid storage disease with myopathy.
Lin P; Li W; Wen B; Zhao Y; Fenster DS; Wang Y; Gong Y; Yan C
J Hum Genet; 2012 Oct; 57(10):679-81. PubMed ID: 22832386
[TBL] [Abstract][Full Text] [Related]
33. Clinical and molecular characteristics of myotonia congenita in China: Case series and a literature review.
Li Y; Li M; Wang Z; Yang F; Wang H; Bai X; Sun B; Chen S; Huang X
Channels (Austin); 2022 Dec; 16(1):35-46. PubMed ID: 35170402
[TBL] [Abstract][Full Text] [Related]
34. Neutral Lipid Storage Disease Associated with the PNPLA2 Gene: Case Report and Literature Review.
Samukawa M; Nakamura N; Hirano M; Morikawa M; Sakata H; Nishino I; Izumi R; Suzuki N; Kuroda H; Shiga K; Saigoh K; Aoki M; Kusunoki S
Eur Neurol; 2020; 83(3):317-322. PubMed ID: 32564019
[TBL] [Abstract][Full Text] [Related]
35. A novel mutation in PNPLA2 leading to neutral lipid storage disease with myopathy.
Ash DB; Papadimitriou D; Hays AP; Dimauro S; Hirano M
Arch Neurol; 2012 Sep; 69(9):1190-2. PubMed ID: 22964912
[TBL] [Abstract][Full Text] [Related]
36. Co-occurrence of DMPK expansion and CLCN1 mutation in a patient with myotonia.
Locci S; Cardani R; Brunori P; Lucchiari S; Comi GP; Federico A; De Stefano N; Meola G; Mignarri A
Neurol Sci; 2021 Dec; 42(12):5365-5368. PubMed ID: 34386887
[TBL] [Abstract][Full Text] [Related]
37. Recessive CLCN1 mutation presenting as Thomsen disease.
Thomas J; Tarleton J; Baker SK
Muscle Nerve; 2008 Nov; 38(5):1515-1517. PubMed ID: 18816629
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of CLCN1 gene mutations in 2 patients with myotonia congenita].
Chen ZT; He J; Chen WJ; Chen SG; Lin JL; Ye QY; Huang HP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):690-2. PubMed ID: 23225051
[TBL] [Abstract][Full Text] [Related]
39. Targeted Next Generation Sequencing in patients with Myotonia Congenita.
Ferradini V; Cassone M; Nuovo S; Bagni I; D'Apice MR; Botta A; Novelli G; Sangiuolo F
Clin Chim Acta; 2017 Jul; 470():1-7. PubMed ID: 28427807
[TBL] [Abstract][Full Text] [Related]
40. Identification of two novel compound heterozygous
Wei Z; Huaxing M; Xiaomei W; Juan W; Xueli C; Jing Z; Junhong G
Neurol Res; 2019 Dec; 41(12):1069-1074. PubMed ID: 31566103
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
